Upgrade to SI Premium - Free Trial

Puma Biotech (PBYI): Solid Start for NERLYNX - Cowen

November 10, 2017 7:49 AM
Cowen analyst, Chris Shibutani, reiterated his Outperform rating on shares of Puma Biotechnology (NASDAQ: PBYI) and increased the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles